Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.55−0.21 (-7.61%)
Close on Nov 18, 2026Market cap $104.71MP/E –Yield –
Scienture operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Scienture's operating income for the twelve months ending Jun 30, 2026 was -$40.07M. For fiscal 2025 it was -$42.59M. The highest annual figure on record is $395.10K in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$42.59M | – |
| FY2024 | Dec 31, 2024 | -$14.70M | – |
| FY2023 | Dec 31, 2023 | -$4.40M | – |
| FY2022 | Dec 31, 2022 | -$2.92M | – |
| FY2021 | Dec 31, 2021 | -$5.29M | – |
| FY2020 | Dec 31, 2020 | -$2.51M | -2101.7% |
| FY2019 | Dec 31, 2019 | $125.22K | – |
| FY2018 | Dec 31, 2018 | -$87.62K | -122.2% |
| FY2017 | Dec 31, 2017 | $395.10K | – |
| FY2016 | Dec 31, 2016 | -$1.01M | – |
| FY2015 | Dec 31, 2015 | -$137.07K | – |
| FY2014 | Dec 31, 2014 | -$1.43M | – |
| FY2013 | Dec 31, 2013 | -$2.08M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.70M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.51M | – |
| Q4 FY2025 | Dec 31, 2025 | -$29.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.36M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.16M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.57M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.21M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.50M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.50M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.49M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.25M | – |
| Q3 FY2023 | Sep 30, 2023 | -$761.68K | – |
| Q2 FY2023 | Jun 30, 2023 | -$599.78K | – |
| Q1 FY2023 | Mar 31, 2023 | -$806.09K | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.06M | – |
| Q3 FY2022 | Sep 30, 2022 | -$218.76K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.10M | – |
| Q1 FY2022 | Mar 31, 2022 | -$968.57K | – |
| Q4 FY2021 | Dec 31, 2021 | -$782.32K | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.30M | -988.8% |
| Q2 FY2021 | Jun 30, 2021 | -$2.57M | – |
| Q1 FY2021 | Mar 31, 2021 | -$644.26K | -442.3% |
| Q4 FY2020 | Dec 31, 2020 | -$2.31M | – |
| Q3 FY2020 | Sep 30, 2020 | $145.82K | -18.0% |
| Q2 FY2020 | Jun 30, 2020 | -$535.28K | -503.4% |
| Q1 FY2020 | Mar 31, 2020 | $188.23K | +9.6% |
| Q4 FY2019 | Dec 31, 2019 | -$357.09K | – |
| Q3 FY2019 | Sep 30, 2019 | $177.85K | +93.7% |
| Q2 FY2019 | Jun 30, 2019 | $132.71K | +322.0% |
| Q1 FY2019 | Mar 31, 2019 | $171.76K | +74.0% |
| Q4 FY2018 | Dec 31, 2018 | -$309.62K | -293.2% |
| Q3 FY2018 | Sep 30, 2018 | $91.83K | +2.5% |
| Q2 FY2018 | Jun 30, 2018 | $31.45K | -35.5% |
| Q1 FY2018 | Mar 31, 2018 | $98.73K | -30.2% |
| Q4 FY2017 | Dec 31, 2017 | $160.25K | – |
| Q3 FY2017 | Sep 30, 2017 | $89.62K | – |
| Q2 FY2017 | Jun 30, 2017 | $48.78K | – |
| Q1 FY2017 | Mar 31, 2017 | $141.45K | – |
| Q4 FY2016 | Dec 31, 2016 | -$54.20K | – |
| Q3 FY2016 | Sep 30, 2016 | -$245.22K | – |
See a number that looks wrong?